About

About

Levostar Biotech Becomes a Member of the International Gene Synthesis Consortium (IGSC)


We are pleased to announce that LevoStar Biotech has officially become a member of the International Gene Synthesis Consortium (IGSC).

This membership reflects LevoStar’s continued commitment to responsible gene synthesis, biosecurity, and trusted biotechnology development.

As our capabilities continue to expand across DNA synthesis, mRNA production, targeted LNP delivery, in vivo CAR-T, and cell and gene therapy, we believe that scientific innovation should advance together with responsible technology practices.

Joining IGSC marks another step in strengthening our global collaboration framework and supporting researchers, biotechnology companies, and pharmaceutical partners with reliable gene synthesis and nucleic acid-related solutions.

 

About the International Gene Synthesis Consortium (IGSC)

The International Gene Synthesis Consortium (IGSC) is an industry-led organization that brings together gene synthesis companies and related organizations worldwide.

The consortium works to promote the responsible use of synthetic nucleic acid technologies by encouraging common practices for sequence screening, customer screening, and biosecurity.

IGSC members support the beneficial development of gene synthesis and synthetic biology while helping reduce the risks associated with misuse of synthetic nucleic acid technologies.

For LevoStar, joining IGSC means becoming part of a global community working toward a shared goal: enabling innovation in biotechnology while maintaining high standards of responsibility and biosecurity.

We look forward to engaging with the IGSC community and continuing to support the development of gene synthesis, RNA therapeutics, synthetic biology, and next-generation genetic medicine.

View the official IGSC member list:

Members | International Gene Synthesis Consortium

Learn more about IGSC:

https://genesynthesisconsortium.org/.